Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Consensus and Guidelines · February 02, 2023

ASCO Guideline Update on Chemotherapy and Targeted Therapy for Patients With Endocrine-Pretreated or HR− MBC

Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update
J. Clin. Oncol 2023 Jan 10;[EPub Ahead of Print], B Moy, RB Rumble, LA Carey

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading